Make your appointment or second opinion with Dana-Farber today to meet with an onsite specialist.

Adult Patients:877-442-3324

Pediatric Patients:888-733-4662

Make Appointment OnlineInternational Patients

Online second opinions

Can’t get to Boston? Explore our Online Second Opinion service to get expert advice from Dana-Farber oncologists.

Request a second opinion

Contact & Directions

Email Dana-Farber

Main Number617-632-3000

Toll-Free Number866-408-DFCI (3324)

Maps & DirectionsContact InformationSend us a Question or Comment

How to Help

Discover the ways to give and how to get involved to support Dana-Farber.

Learn More
Give now

  • Dana-Farber/New Hampshire Oncology-Hematology

    Practical Applications for Lung Cancer Screening and Targeted Therapies

    A free educational event for clinicians

    Tuesday, May 21, 2013
    5:30 – 7:15 p.m.
    Dana-Farber/New Hampshire Oncology-Hematology
    40 Buttrick Road, Londonderry, NH

    Please join us to review and discuss the latest recommendations in screening for and treating lung cancer. This course has been developed for primary care physicians, pulmonologists, hematologists/oncologists, nurse practitioners, and other interested clinicians. Faculty will present updates that will help providers:

    • Describe best practices for managing screening for lung cancer
    • Interpret and utilize screening results in clinical practice
    • Incorporate molecular diagnostics in treatment decisions
    • Apply advances in targeted treatment for lung cancer to clinical practice

    This course is offered by Dana-Farber/New Hampshire Oncology-Hematology and Southern New Hampshire Area Health Education Center.


    This course is free for interested providers. Space is limited.

    To register, contact Carla LaPorte at 603-552-9125 or by May 10.


    5:30 p.m.

    Dinner and Networking

    6:00 p.m.

    Frederick M. Briccetti, MD 

    6:05 p.m.

    Lung Cancer Screening: Making Sense of the Data
    Christopher Lathan, MD, MS, MPH 

    6:40 p.m.

    Advances in Genotype-directed Therapies
    Geoffrey R. Oxnard, MD 

    7:15 p.m.

    Concluding Remarks
    Frederick M. Briccetti, MD 

    7:35 p.m.


    Frederick M. Briccetti, MD
    Medical Director, Dana-Farber/New Hampshire Oncology-Hematology;
    Instructor in Medicine, Harvard Medical School

    Christopher Lathan, MD, MS, MPH
    Medical Oncologist, Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute;
    Assistant Professor of Medicine, Harvard Medical School

    Geoffrey R. Oxnard, MD
    Medical Oncologist, Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute;
    Instructor in Medicine, Harvard Medical School


    The Southern NH Area Health Education Center, accredited by the NH Medical Society, designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    The Southern NH Area Health Education Center is approved as a provider of continuing education in nursing by the New Hampshire Nurses' Association Commission on Continuing Education which is accredited as an approver of Continuing Nursing Education by the American Nurses Credentialing Center's Commission on Accreditation.

    This continuing education activity has been approved for 1.0 contact hours. SNHAHEC Activity Number: 1086

  •   Email
  •   Print
  •   Share
  • Education and Training

    • Learn about additional CME programs offered by Dana-Farber.